List of Excipients in API SELPERCATINIB
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing SELPERCATINIB
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | RETEVMO | selpercatinib | 0002-3977 | ALCOHOL | 2038-10-10 |
| Eli Lilly and Company | RETEVMO | selpercatinib | 0002-3977 | AMMONIA | 2038-10-10 |
| Eli Lilly and Company | RETEVMO | selpercatinib | 0002-3977 | BUTYL ALCOHOL | 2038-10-10 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for SELPERCATINIB
Excipient focus: ALCOHOL
SELPERCATINIB drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
SELPERCATINIB drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
SELPERCATINIB drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
SELPERCATINIB drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
SELPERCATINIB drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
SELPERCATINIB drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
SELPERCATINIB drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
SELPERCATINIB drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
SELPERCATINIB drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
SELPERCATINIB drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
SELPERCATINIB drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
SELPERCATINIB drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
SELPERCATINIB drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | selpercatinib | 0002-3977 |
| >Company | >Ingredient | >NDC |
SELPERCATINIB drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
